1664286292
The Science of Skin

Advertise on podcast: The Science of Skin

Rating
★★★★★
5
from
69 reviews
This podcast has
145 episodes
Language
English
Date created
2023/01/10
Latest episode
2026/11/12
Average duration
23 min.
Release period
6 days

Description

The Science of Skin is a podcast for those who want to be in-the-know about what’s trending, and what’s next in topical skincare.  Hosts  Dr. Patti Farris and Dr. Ted Lain are board certified dermatologist, recognized experts in topical skincare and co-founders of the Science of Skin Summit. In each episode, The Science of Skin will give you an insider’s view of the skincare industry.  You will hear from research scientists, formulators, and leading physician experts on how products are developed, tested, and used to treat medical and cosmetic patients.   So, if you’re interested in a behind the scenes look at what makes the skincare industry tick, subscribe to The Science of Skin today. Thanks for listening!   You can slo find us on YouTube: https://www.youtube.com/@scienceofskinpodcast Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

Unlock The Science of Skin podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from The Science of Skin podcast


Acne Treatment That Lasts: The Clear Skin Method
2026/11/12
Recording live from the 2026 Science of Skin Summit in Austin, Dr. Ted Lane sits down with Stephanie Criscione, Senior Director of Education and Clinic at Face Reality Skincare. Face Reality began 21 years ago as a small acne clinic, founded by an esthetician who had lived with severe acne into her forties. Today it is a brand built almost entirely around one condition. Stephanie walks through the Clear Skin Method, Face Reality’s four-part approach to acne: clinically effective products, home care tailored to each patient, in-office treatments, and lifestyle coaching. She and Dr. Lane talk about why acne in a 16-year-old and acne in a 60-year-old need different treatment, and why tolerability drives compliance. They also cover the role of mandelic acid, a gentler alpha hydroxy acid, in getting patients clear without redness or irritation. They also get into the clinical research. Most lines built on monographed acne ingredients don’t invest in studies, but Face Reality tested its full regimen on participants from across the U.S. with a range of ages and Fitzpatrick skin types. The study reported clear skin in about 12 to 16 weeks. Finally, they look at what happens after acne clears, starting with the newly launched Age Adaptive Clearing Serum. It combines alpha hydroxy acids, a gentle adapalene precursor, and succinic acid to help patients keep their results while treating secondary concerns like texture and aging. Stephanie also explains why multitasking products around a $250 regimen may suit younger patients who are budgeting for both skincare and in-office treatments. Topics covered: The four parts of the Clear Skin MethodWhy mandelic acid is gentler on the skinClinical proof for whole regimens, not just single ingredientsTreating acne across climates, ages, and skin typesLife after acne: the Age Adaptive Clearing SerumThe move away from 10-step routines toward multifunctional productsHave questions or episode ideas? Email [email protected]. If you enjoyed this episode, please share it with a colleague and leave a five-star review.
Integrated Skincare for Post-Inflammatory Hyperpigmentation in Skin of Color
2026/11/10
Live from Paris at the Skin Alliance meeting, board-certified dermatologist Dr. Patty Farris sits down with Dr. Jared Jagdeo, professor at SUNY Downstate and director of its Skin of Color Center. They discuss his newly published investigator-initiated trial in the April 2026 Journal of Drugs in Dermatology (lead author Dr. Zafar): “An Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color.” Post-inflammatory hyperpigmentation (PIH) can follow a rash or a cosmetic procedure, has no FDA-approved treatment, and can deeply affect a patient’s confidence and quality of life. Dr. Jagdeo explains how his team paired two in-office SkinCeuticals Pigment Balancing Peels, six weeks apart, with a simple at-home routine: a gentle LHA cleanser, Discoloration Defense, Daily Brightening UV Defense sunscreen, and Hydrating B5 Gel. Over 12 weeks, the study tracked patient satisfaction as its primary outcome, along with quality-of-life scores, photographic improvement, and objective Mexameter readings of melanin and redness. Dr. Farris and Dr. Jagdeo also cover: Why multimodal ingredients like tranexamic acid, niacinamide, and kojic acid make a strong anti-pigment combination Why Dr. Jagdeo avoids hydroquinone because of the risk of ochronosis How to “go slow” with procedures and energy-based devices in darker skin types When to start the at-home regimen after a peel Why a simple, affordable routine that patients will actually stick to matters most Have a question or an idea for a future episode? Email [email protected]. ⚠️ This content is for educational and informational purposes only and reflects the personal clinical opinions and experiences of the speakers. It is not medical advice. Consult a licensed healthcare provider for questions about diagnosis or treatment. If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!
Exosomes, Growth Factors & the Future of Regenerative Skincare
2026/11/05
Live from day three of the Summit in Austin, Texas, board-certified dermatologist Dr. Patti Farris sits down with Keith O’Briant, CEO of Hydrinity, to talk about how a regenerative medicine background led to one of the most science-driven brands in aesthetics. Keith shares how Hydrinity began in wound healing and radiation oncology, why its heat-free hyaluronic acid works differently, and how biomimetic exosomes are changing the way active ingredients reach the skin. He also introduces two new launches: a peel pad that combines encapsulated retinal, a five-acid blend, and an acne-targeting peptide, and CellThera Advanced Overnight Repair Cream, which delivers epidermal growth factors inside an exosome for firming, hydration, and barrier support. Dr. Farris and Keith also discuss the rise of longevity skincare, why nighttime is the ideal time for skin repair, how Gen Z is changing the skincare conversation, and why seeing a professional still matters more than advice from social media. Which part of skincare science do you want us to explore next? Tell us in the comments. ⚠️ This content is for educational and informational purposes only and reflects the personal clinical opinions and experiences of the speakers. It is not medical advice. Consult a licensed healthcare provider for questions about diagnosis or treatment.
Hyperpigmentation in Skin of Color: Thiamidol, Melasma & Visible Light
2026/11/03
Why is hyperpigmentation so hard to treat in skin of color, and what actually works? Recorded live on day three of the Science of Skin Summit in Austin, board-certified dermatologist Dr. Patty Farris talks with Dr. Cheri Frey, residency program director at Howard University and an expert in treating hyperpigmentation, melasma, and pigmentary disorders. They start with the story behind thiamidol, a new ingredient that Beiersdorf found by screening thousands of molecules. It was chosen for how well it blocks human tyrosinase, not the mushroom tyrosinase most labs had relied on. From there, they look at why patients with Fitzpatrick skin types V and VI are underrepresented in hyperpigmentation clinical trials. They also explain how visible light combined with UVA drives pigmentation in deeper skin tones, and how to protect skin with tinted sunscreen, iron oxides, and antioxidants. In this episode: How thiamidol was discovered and why human tyrosinase testing mattersThe research gap for skin of color in hyperpigmentation clinical trialsVisible light, UVA, and hyperpigmentation in Fitzpatrick skin types IV to VIWhy most visible light exposure comes from the sun, not your phone or screensTinted sunscreens, iron oxides, and antioxidants for visible light protectionUnderdiagnosis and misdiagnosis of melasma, lichen planus pigmentosus, and PIH in darker skinSunscreen misinformation on social media and how patients can choose the right productsUsing the Radiant Tone regimen with thiamidol and licochalcone A for post-inflammatory hyperpigmentation (PIH), melasma, and solar lentiginesAdding a dark spot serum to an acne routine, and using thiamidol before laser treatments to lower the risk of PIHHave a question or an idea for a future episode? Email [email protected]. ⚠️ This content is for educational and informational purposes only and reflects the personal clinical opinions and experiences of the speakers. It is not medical advice. Consult a licensed healthcare provider for questions about diagnosis or treatment. If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!
Fixing Dermatology’s Purchasing Problem
2026/10/29
In this special post-Summit episode, Dr. Patti Farris sits down with Errol Clarke Jr., winner of the Investor’s Choice Award at the 2026 Science of Skin Summit’s innovation session. Errol, a recent Harvard MBA and former private equity investor, grew up inside dermatology as the son of Dr. Valerie Callender and practice executive Errol Clarke Sr. He’s now building a procurement and inventory management platform designed specifically for dermatology and aesthetic practices. Errol explains how a simple question to his mom (“How do we do our purchasing?”) led him to discover that nearly every practice he spoke with was ordering from dozens of vendors through texts, emails, phone calls, and scattered portals. His platform brings all of that into one place, tracking tiered pricing, back orders, invoice accuracy, expiring products, and samples, while letting practices keep their rep relationships. The result, he says, can be savings of 10% or more on current spend, plus clearer margins that help practices price procedures and products with confidence. Patti and Errol also discuss how the platform covers both aesthetic and medical supplies for hybrid practices, why device makers and emerging skincare brands see value in it, and how lessons from successful dental and veterinary procurement software shaped his approach. Whether you run a solo practice or a growing multi-location group, this conversation offers a look at how smarter operations can protect your margins and free up your time.
Rhapsido (Remibrutinib) Safety in Chronic Urticaria
2026/10/27
How safe is remibrutinib (Rhapsido) for chronic spontaneous urticaria (CSU)? Dermatologists Dr. Ted Lain and Dr. Jason Hawkes break down bleeding risk, labs, drug interactions and patient counseling. This sponsored episode of the Science of Skin Podcast, supported by Novartis, focuses on the safety of remibrutinib, an oral BTK inhibitor for chronic hives. Dr. Hawkes, Principal Investigator and Chief Scientific Officer at Oregon Medical Research Center, explains why the "bleeding events" in the phase 3 REMIX-1 and REMIX-2 trials were mostly mild bruising and petechiae, how fast onset and a short half-life help with surgical planning, and what the label really means by hepatic impairment (Child-Pugh B or C, not routine LFTs). They also cover live vaccines, CYP3A4 drug interactions, the adverse event profile and which urticaria patients are a good fit, including those with angioedema or prior omalizumab failure. Have a question or an idea for a future episode? Email [email protected]. ⚠️ This content is for educational and informational purposes only and reflects the personal clinical opinions and experiences of the speakers. It is not medical advice. Consult a licensed healthcare provider for questions about diagnosis or treatment. If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!
Acne Treatment with Lasers & Energy-Based Devices: The Skincare Algorithm
2026/10/20
Which skincare should you use when acne is treated with lasers, IPL, photodynamic therapy (PDT), or microneedling? Board-certified dermatologist Dr. Ted Lain is in Paris at the L'Oréal Skin Alliance conference with Dr. Cheng-Feng Zhang, Professor of Dermatology at Huashan Hospital, Fudan University in Shanghai. Dr. Zhang is an expert in acne, pigmentary disorders, and cosmetic dermatology. Both doctors helped write a new international consensus paper: a practical algorithm for combining skincare with energy-based devices (EBDs) for acne. It was published in February 2026 in the Journal of Drugs in Dermatology (JDD), and Dr. Jill Waibel is the first author. In this episode they explain why the goal of acne treatment should be completely clear skin, and how prescription therapy, in-office procedures, and a good skincare routine work together to get there. In this episode: Why oxidative stress and reactive oxygen species (ROS) drive acne inflammation and acne scarringHow post-inflammatory erythema (PIE) and post-inflammatory hyperpigmentation (PIH) relate to acne scarsAntioxidant serums for acne-prone skin: silymarin, vitamin C (L-ascorbic acid), and ferulic acidWhy daily broad-spectrum sunscreen matters for acne patientsAcne and skin barrier dysfunction: ceramides, cholesterol, and fatty acids in moisturizersGentle, fragrance-free, non-comedogenic cleansers, and whether double cleansing makes senseEnergy-based devices for acne and acne scars: blue light, red light, IPL, PDT, pulsed dye laser, fractional laser, radiofrequency, and microneedlingWhen to stop retinoids before laser and light procedures, and when to start them againHave a question or an idea for a future episode? Email [email protected]. ⚠️ This content is for educational and informational purposes only and reflects the personal clinical opinions and experiences of the speakers. It is not medical advice. Consult a licensed healthcare provider for questions about diagnosis or treatment. If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!
The Accidental Birth of SkinMedica TNS
2026/10/13
What started as a failed treatment for venous ulcers became one of the most influential products in professional skincare. Dr. Mitchel Goldman, co-founder of SkinMedica, tells the story of how TNS was created and why it was a "longevity" product decades before the term existed. Dr. Ted Lain sits down with Dr. Goldman, a world-renowned cosmetic dermatologist, former ASDS president, and director of cosmetic and laser surgery at Platinum Dermatology. Dr. Goldman shares how a passing comment from Dr. Richard Fitzpatrick about the skin around a wound led to the first growth factor serum. He also talks about the hard financial realities of building a skincare company and why physician-dispensed brands that invest in research stand apart. They also cover: Why the full "gemish" of growth factors, secretomes, and exosomes outperforms any single ingredientHow Dr. Goldman rotates growth factor products and lets patients' results guide the choicePre- and post-procedure skincare, and the shift toward priming fibroblasts with topical rapamycinWhether skin longevity needs multi-targeted or single-pathway productsDr. Goldman's personal cautionary tale about systemic anti-aging therapies, and why he favors topicalsHow a topical sodium bicarbonate made for athletes is now being studied in oncologyWhy aesthetic dermatology deserves a bigger place in residency trainingQuestions or ideas for future episodes? Email us at [email protected]. If you enjoyed this conversation, please subscribe, leave a five-star rating, and share it with a colleague. Follow and Listen to the Podcast Here:  🍎 Apple Podcasts — https://podcasts.apple.com/us/podcast/skincare-confidential/id1664286292 🎵 Spotify — https://open.spotify.com/show/033Vffp4W8A72pVRVaoWzs 📦 Amazon Music — https://music.amazon.com/podcasts/7de48e5e-f450-466b-a0f4-f2275b67757f/skincare-confidential 💚 iHeart Radio — https://www.iheart.com/podcast/269-the-science-of-skin-269540115/ 📻 Audacy — https://www.audacy.com/podcast/skincare-confidential-4398f Disclaimer: This episode is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.
Menopause and Your Skin: The Pilocutaneous Syndrome of Menopause
2026/10/08
Menopause is having a moment, but board-certified dermatologist and Menopause Society Certified Practitioner Dr. Corinne Erickson was connecting hormones and skin health long before it was trending. In this episode of the Science of Skin podcast, host Dr. Patti Farris talks with Dr. Erickson about how dermatologists can better care for women across the menopause continuum, from the first perimenopausal shifts to the postmenopausal years. Dr. Erickson explains her framework for making sense of the long list of concerns many women bring to the exam room, including hair loss, acne, unwanted facial hair, itching, sensitivity, and dryness. She traces them back to two key drivers: estrogen decline and relative androgen excess. The conversation covers what happens to collagen, hydration, and barrier function when estrogen drops, why vaginal estradiol belongs in the dermatologist's toolkit, what the evidence does and doesn't show about topical estrogen for facial aging and crepey skin, and how she approaches female pattern hair loss, including why she asks about hair at the start of every skin exam. She also introduces a new term she has proposed for dermatology: the Pilocutaneous Syndrome of Menopause (PSM). Like genitourinary syndrome of menopause and musculoskeletal syndrome of menopause, it gives clinicians and patients a shared name and a treatment framework grounded in the underlying hormonal changes. Read Dr. Erickson's preprint, "The Pilocutaneous Syndrome of Menopause":  https://figshare.com/articles/preprint/The_Pilocutaneous_Syndrome_of_Menopause/33090086?file=66996713 If you enjoy the Science of Skin podcast, please subscribe, leave a review, and share this episode with a colleague or friend.
Rhapsido (Remibrutinib) for Chronic Spontaneous Urticaria: Phase 3 Efficacy Data
2026/10/06
Is there finally a fast-acting oral treatment for chronic hives? In this episode of the Science of Skin Podcast, board-certified dermatologist Dr. Ted Lain is joined by Dr. Naiem Issa, a dermatologist in Northern Virginia and assistant professor of dermatology at the University of Miami and George Washington University, to break down the phase 3 clinical trial results for Rhapsido (remibrutinib), the first oral BTK inhibitor for chronic spontaneous urticaria (CSU). Dr. Issa explains how Bruton's tyrosine kinase (BTK) inhibition works inside the mast cell to block the signals that lead to degranulation and histamine release, and why remibrutinib's covalent, highly selective binding helps explain its rapid onset and durable results. The doctors then walk through the pivotal trial data, including reductions in the Hives Severity Score (HSS7), Itch Severity Score (ISS7), and Urticaria Activity Score (UAS7). Patients saw about a 40% reduction in hives as early as week one, around 70% by week 12, and continued improvement through 52 weeks. Nearly 28% of patients reached UAS7 = 0, meaning complete absence of hives and itch, at week 12 compared with 6.5% on placebo, rising to almost 46% at one year. They also discuss the challenging trial population, which included patients with severe disease uncontrolled on up to four times the standard dose of second-generation antihistamines, many with angioedema, and about a third with prior anti-IgE biologic therapy such as omalizumab. Dr. Lain and Dr. Issa cover angioedema-free weeks, what complete control means for quality of life, how this data may change CSU treatment for dermatologists and allergists, and what new data on even faster onset may be coming soon. This episode is sponsored by Novartis with content independently created by the Science of Skin podcast. ⚠️ This content is for educational and informational purposes only and reflects the personal research findings and opinions of the speakers. It is not medical advice. The discussion involves animal studies and experimental research; consult a licensed healthcare provider for questions about your own health. If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!
Can a Topical Serum Work Like Botox? Dermatologist Breaks Down P-TIOX
2026/09/29
Can a topical serum work like a neurotoxin? Recorded live in Paris, Dr. Ted Lain sits down with Dr. Peter Bjerring to find out. Dr. Bjerring is a professor of dermatology at Aalborg University Hospital in Denmark, a laser pioneer who helped develop IPL technology, and a Knight of the Order of the Dannebrog. Together they break down SkinCeuticals P-TIOX, a serum built around two viper-venom-derived neuropeptides. One acts presynaptically, like botulinum toxin. The other blocks acetylcholine receptors on the muscle side. Both are small enough to penetrate the skin, which injectable toxins can't do. Dr. Bjerring walks through two of his clinical studies. In a split-forehead sweat study using the Minor iodine-starch test, the treated side showed little to no sweating after just three applications. That suggests the peptides really do reach their targets in the skin. In an 8-week, all-male study of 36 participants across multiple ethnicities, twice-daily use reduced forehead and glabellar lines by about 15%. Crow's feet, nasolabial folds, and even marionette lines also improved, and results kept getting better between weeks 4 and 8. The conversation also covers the supporting ingredients: 5% polyhydroxy acid for gentle exfoliation, niacinamide for barrier support, tone, and redness, and Laminaria digitata for antioxidant and collagen support. They discuss why so many self-reported sensitive-skin participants had no irritation, and how P-TIOX may pair with injectable neurotoxins to target the fine, superficial texture lines that injections miss. If you enjoyed this episode, please leave a 5-star rating and share it with a colleague. Word of mouth helps our podcast grow! Have questions or ideas for future episodes? Email us at [email protected]. Disclaimer: This clip is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.
The Science of Slowing Aging: Rapamycin, Genes, and the Quest for a Longer Health Span
2026/09/22
In this episode of the Science of Skin Podcast, Dr. Ted Lain talks with Dr. Rich Miller, professor of pathology at the University of Michigan and director of the Paul F. Glenn Center for Aging Research, about the science of slowing biological aging. Dr. Miller explains why lifespan and health span move together, not in opposition, and walks through decades of research using genetic mutants, calorie-restricted diets, and drugs like rapamycin, acarbose, canagliflozin, and 17 alpha-estradiol to extend lifespan in mice. The conversation covers how these interventions work through pathways like mTOR and glucose regulation, why some drugs affect males and females differently, and the surprising finding that many of these anti-aging effects hold up even when treatment starts in middle age rather than early in life. The two also discuss the challenge of translating mouse research to humans, Dr. Miller's work developing "aging rate indicators" that could make human drug trials for aging far more practical, and his call for more dermatology involvement in aging research — including his hope to see skin aging studied alongside the organs his lab has already examined. The episode closes with a candid take on supplement industry claims and what the current evidence actually supports for slowing aging today. ⚠️ This content is for educational and informational purposes only and reflects the personal research findings and opinions of the speakers. It is not medical advice. The discussion involves animal studies and experimental research; consult a licensed healthcare provider for questions about your own health. If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!
Chronic Urticaria Explained: BTK Inhibitors & Remibrutinib
2026/09/15
In this episode of the Science of Skin Podcast, Dr. Ted Lain sits down with Dr. Sarina Elmariah, MD, PhD, professor of dermatology at UC San Francisco and director of the UCSF Center for Itch and Neurosensory Disorders, for a deep dive into chronic spontaneous urticaria (CSU). Dr. Elmariah breaks down the role of Bruton's tyrosine kinase (BTK) in mast cell degranulation and explains how it sits at the center of the histamine release cascade. The conversation covers the difference between Type I (auto-allergic) and Type IIb (autoimmune) CSU pathways, available diagnostic tools like autologous serum skin testing and basophil activation testing, and why BTK appears to be a common thread across nearly all CSU mechanisms — including many inducible urticarias. The two also discuss remibrutinib (brand name Rhapsido), a BTK inhibitor newly FDA-approved for CSU, and what makes its binding mechanism distinct from earlier BTK inhibitors. They close with a look beyond histamine at the other inflammatory mediators — proteases, leukotrienes, prostaglandins, and cytokines — that help explain why so many CSU patients don't respond to antihistamines alone, and why angioedema tends to linger longer than a typical urticarial wheel. This episode is sponsored by Novartis with content independently created by the Science of Skin podcast. ⚠️ This content is for educational and informational purposes only and reflects the personal research findings and opinions of the speakers. It is not medical advice. The discussion involves animal studies and experimental research; consult a licensed healthcare provider for questions about your own health. If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow!
K-Beauty Decoded: The Science Behind Glass Skin, Snail Mucin & Korean Sunscreens
2026/09/08
Korean skincare is everywhere on social media — but how much of it is backed by real dermatologic science? In this episode of The Science of Skin Podcast, Dr. Patti Farris sits down with Dr. Jane Yoo, board-certified dermatologist, fellowship-trained Mohs surgeon, and "The K-Beauty Dermatologist," to separate fact from TikTok fiction. They trace K-beauty's roots from the Goryeo and Joseon dynasties through the Hallyu wave, then dig into the science: ceramide-dominant, barrier-centric formulations, low-pH cleansers, and why "glass skin" is more about consistent barrier care (and good lighting) than any single product. Dr. Yoo also breaks down the real evidence behind snail mucin, PDRN and PN, exosomes, and silica spicules — including where the hype outpaces the data — plus whether double cleansing is really necessary and why Korean sunscreen filters like bemotrizinol (Tinosorb S) may be the biggest public health advance in photoprotection in 25 years. In this episode: The real history of K-beauty, from royal court rituals to global export What actually causes "glass skin" (and what doesn't) The truth about snail mucin, PDRN/PN, exosomes, and spicules Do you really need to double cleanse? Why newly approved filters like bemotrizinol could change US sunscreens Tinted, visible-light-blocking sunscreens for skin of color Have a question or an idea for a future episode? Email [email protected]. Join us at the Science of Skin Summit, September 17-20 in Austin, TX, or the new Science of Skin Longevity Conference in Scottsdale, February 2027. Learn more at scienceofskinsummit.com If you enjoyed this episode, please leave a 5-star rating and share with a colleague — word of mouth helps our podcast grow! ⚠️ This content is for educational and informational purposes only and reflects the personal clinical opinions and experiences of the speakers. It is not medical advice. Consult a licensed healthcare provider for questions about diagnosis or treatment.
Inside DermFluencer University: Building the Next Generation of Medical Creators
2026/09/01
In this episode of the Science of Skin Podcast, Dr. Patti Farris sits down with Dr. Dustin Portela and Mimi Banks (Principal, Mimi Banks Social) to talk all things DermFluencer University — the influencer education track heading into its third year at the Science of Skin Summit in Austin, TX (September 17–20). Dustin and Mimi trace the program's origin from a single standing-room-only session to a full two-day experience combining a hands-on masterclass with practical, camera-ready workshops. They dig into why physicians need to show up in the spaces where health misinformation spreads — especially around topics like sunscreen and skin cancer — and share the systems, batching techniques, and content frameworks that make creating sustainable for busy clinicians. The conversation also covers Med Creator 101, the podcast-turned-course born out of Dustin and Mimi's countless one-on-one conversations with physicians at AAD 2024, now distilled into an eight-module course covering everything from content hooks to HIPAA-conscious posting. Whether you're a dermatologist, NP, PA, or aesthetician curious about content creation, this episode offers a behind-the-scenes look at how to build an authentic, science-backed presence online — imperfections and all. Topics covered: DermFluencer University · Med Creator 101 · content batching & systems · combating skincare misinformation · camera presence & branding workshops · Science of Skin Summit 2026

Podcast reviews

Read The Science of Skin podcast reviews


5 out of 5
69 reviews
★★★★★
Ramonatv 2026/09/18
Great podcast
I never miss it. Ted & Patti have great guests and informative conversations.
★★★★☆
ShenJohn 2026/08/23
Topical Steroid Side Effects
You literally did not mention any side effects from topical steroids. I listened to the entire episode, hoping to learn why they are bad. Other than, ...
★★★★★
Cptn_T 2025/10/17
Top Podcast
If you want to know about all things skin, stop here. These are two of the top dermatologists giving you real information, timely, science backed and ...
★★★★★
Skincarelover1996 2025/10/15
So helpful
Absolutely love this. Conversational format on topics that patients and derms care about.
★★★★★
KayleeFinds 2025/10/15
Great Content
Very informative
★★★★★
LTF525 2025/10/15
REAL dermatologist talking about REAL skincare issues
Highly recommend this podcast. So informative, with real content by real doctors. Don’t miss this one!!
★★★★★
Stamina Cosmetics 2025/04/26
Dermwithstamina 😉💪 loves integrated skin care with lasers. Thanks Patty & Jill.
Thanks for excellent podcast on RG6 with ablative lasers 👏
★★★★★
ah564 2024/12/11
An incredible resource
Skincare Confidential has been an invaluable addition to my residency education- helping me think critically about the unique role dermatologists can ...
★★★★★
CBC2477 2023/06/17
Informative and insightful
Keep these episodes coming. As someone who is obsessed with skincare and having a routine to keep my skin looking hydrated and fresh, this podcast has...
★★★★★
Amey-door 2023/05/27
So informative!
I’m not a dermatologist but I absolutely LOVE this podcast! I’m a college student interested in medicine and have thoroughly enjoyed learning all the ...
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on The Science of Skin relevant audience podcasts


What do you want to promote?